| Literature DB >> 27196074 |
E Sahin1, C Cingi2, G Eskiizmir3, N Altintoprak4, A Calli5, C Calli6, I Yilgör7, E Yilgör7.
Abstract
Alloplastic materials are frequently used in facial plastic surgeries such as rhinoplasty and nasal reconstruction. Unfortunately, the ideal alloplastic material has not been found. This experimental study evaluates the tissue response and durability of five novel polymers developed as an alloplastic material. In this experimental study involving a tertiary university hospital, six subcuticular pockets were formed at the back of 10 rabbits for the implantation of each polymer and sham group. Each pocket was excised with its adjacent tissue after three months, and collected for histopathological examination. Semi-quantitative examination including neovascularisation, inflammation, fibrosis, abscess formation, multinucleated foreign body giant cells was performed, and integrity of polymer was evaluated. A statistical comparison was performed. No statically significant difference was detected in neovascularisation, inflammation, fibrosis, abscess formation and multinucleated foreign body giant cells when a paired comparison between sham and polymer II, III and IV groups was performed individually. Nevertheless, the degree of fibrosis was less than sham group in polymer I (p = .027) and V (p = .018), although the other variables were almost similar. The integrity of polymers III (9 intact, 1 fragmented) and IV (8 intact, 2 absent) was better than the other polymers. These novel synthetic polymers could be considered as good candidates for clinical applicability. All polymers provided satisfactory results in terms of tissue response; however, fibrovascular integration was higher in polymers II, III and IV. In addition, the durability of polymer III and IV was better than the others. © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.Entities:
Keywords: Alloplastic material; Bioavailability; Nasal reconstruction; Polymer; Rhinoplasty
Mesh:
Substances:
Year: 2016 PMID: 27196074 PMCID: PMC4907156 DOI: 10.14639/0392-100X-965
Source DB: PubMed Journal: Acta Otorhinolaryngol Ital ISSN: 0392-100X Impact factor: 2.124
Fig. 1.The distribution of tissue response [neovascularisation (A), inflammation (B), fibrosis (C), abscess formation (D), foreign body giant cell (E) and integrity of polymers (F)] in polymer and sham groups.
Statistical comparison between polymer and sham groups according to neovascularisation, inflammation, fibrosis, abscess formation and multinucleated foreign body giant cells.
| Neovascularisation | Inflammation | Fibrosis | Abscess formation | Multinucleated foreign body giant cell | |
|---|---|---|---|---|---|
| Polymer I-Sham group | 0.301 | 0.779 | 0.027† | 0.305 | 0.136 |
| Polymer I-Polymer II | 0.041† | .550 | 0.036† | 1.000 | 1.000 |
| Polymer I-Polymer III | 0.580 | 0.682 | 0.364 | 0.531 | 0.136 |
| Polymer I-Polymer IV | 0.327 | 0.912 | 0.148 | 0.305 | 1.000 |
| Polymer I-Polymer V | 0.301 | 0.450 | 0.470 | 0.305 | 0.606 |
| Polymer II-Sham group | 0.270 | 0.221 | 0.329 | 0.305 | 0.136 |
| Polymer II-Polymer III | 0.148 | 0.246 | 0.319 | 0.531 | 0.136 |
| Polymer II-Polymer IV | 0.118 | 0.680 | 0.587 | 0.305 | 1.000 |
| Polymer II-Polymer V | 0.494 | 0.099 | 0.043† | 0.305 | 0.606 |
| Polymer III-Sham group | 0.801 | 0.392 | 0.264 | 0.136 | NS |
| Polymer III-Polymer IV | 0.788 | 0.566 | 0.815 | 0.136 | 0.136 |
| Polymer III-Polymer V | 0.638 | 0.767 | 0.264 | 0.136 | 0.060 |
| Polymer IV-Sham group | 0.881 | 0.514 | 0.418 | NS | 0.136 |
| Polymer IV-Polymer V | 0.400 | 0.244 | 0.144 | NS | 0.606 |
| Polymer V-Sham group | 0.645 | 0.343 | 0.018† | NS | 0.060 |
NS: Not computed because parameter was a constant.
Statistically significant (p<0.05).
Fig. 2.Photomicrograph showing the intact implant material (haemotoxylin and eosin, x40). (A), Infiltration of the connective tissue capsule surrounding the implant by the inflammatory infiltrate which is mainly composed of lymphocytes and plasma cells (B), accompanied by eosinophils in some (C).